BIIB021

DRUG3 trials

Sponsors

Biogen

Conditions

Advanced Solid TumorsBreast CancerGIST

Phase 1

Once or Twice Daily Administration of BIIB021 to Subjects With Advanced Solid Tumors

CompletedNCT00618735

BiogenAdvanced Solid Tumors

Start: 2008-02-29End: 2010-12-31Updated: 2016-12-29

Phase 2

An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST)

CompletedNCT00618319

Start: 2008-02-29End: 2010-04-30Updated: 2015-10-02

Hormone Receptor Positive Metastatic Breast Cancer (HR+ mBC) BIIB021 Plus Aromasin Schedule Finding

CompletedNCT01004081

BiogenBreast Cancer

Start: 2009-11-30End: 2011-10-31Updated: 2015-10-02